TNF and triple-negative breast carcinoma: The underlying mechanism may be related to the sharp decline of angiogenic factors (VEGFA, VEGFR, and neuropilin 1), the reduction in extracellular matrix components (metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase), triple-negative breast cancer-induced inflammation [tumor necrosis factor-alpha (TNF-α)], and an increase in nerve growth factor receptors (nerve growth factor p75 and semaphorin 3A).